Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History | Funding Information
International Journal of Clinical Pharmacology & Pharmacotherapy Volume 1 (2016), Article ID 1:IJCPP-114, 4 pages
https://doi.org/10.15344/2456-3501/2016/114
Review Article
A Promising but Challenging Strategy for Cancer Treatment: Disruption of Myc-Max Heterodimerization

Hyojin Kim1, Minjin Yoo2 and Kwan-Young Jung2,3*

1Department of Chemistry, Sogang University, 5 Baekbeom-ro, Mapo-gu, Seoul 04107, Republic of Korea
2Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea
3Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea
Dr. Kwan-Young Jung, Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea, Tel: +82-42-860-7692; E-mail: krjeong@krict.re.kr
16 May 2016; 16 July 2016; 18 July 2016
Kim H, Yoo M, Jung KY (2016) A Promising but Challenging Strategy for Cancer Treatment: Disruption of Myc-Max Heterodimerization. Int J Clin Pharmacol Pharmacother 1: 114. doi: https://doi.org/10.15344/2456-3501/2016/114
This work was supported by Korea Research Institute of Chemical Technology (Grant No. KK-1507-C14 and KK-1607-C09).
© 2016 Kim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Chen BJ, Wu YL, Tanaka Y, Zhang W (2014) Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics. Int J Biol Sci 10: 1084-1096 [CrossRef] [Google Scholar] [PubMed]
  2. Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211-1217 [CrossRef] [Google Scholar] [PubMed]
  3. Nair SK, Burley SK (2003) X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 112: 193-205 [CrossRef] [Google Scholar] [PubMed]
  4. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, et al. (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151: 56-67 [CrossRef] [Google Scholar] [PubMed]
  5. Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635-645 [CrossRef] [Google Scholar] [PubMed]
  6. Zhang W, Kater AP, Widhopf GF, Chuang HY, Enzler T, et al. (2010) B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 107: 18956-18960 [CrossRef] [Google Scholar] [PubMed]
  7. Lawlor ER, Soucek L, Brown-Swigart L, Shchors K, Bialucha CU, et al. (2006) Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res 66: 4591-4601 [CrossRef] [Google Scholar] [PubMed]
  8. Sodir NM, Swigart LB, Karnezis AN, Hanahan D, Evan GI, et al. (2011) Endogenous Myc maintains the tumor microenvironment. Genes Dev 25: 907-916 [CrossRef] [Google Scholar] [PubMed]
  9. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, et al. (2010) Selective inhibition of BET bromodomains. Nature 468: 1067-1073 [CrossRef] [Google Scholar] [PubMed]
  10. Muller S, Filippakopoulos P, Knapp S (2011) Bromodomains as therapeutic targets. Expert Rev Mol Med 13: e29 [CrossRef] [Google Scholar] [PubMed]
  11. Sanchez R, Meslamani J, Zhou MM (2014) The bromodomain: from epigenome reader to druggable target. Biochim Biophys Acta 1839: 676- 685 [CrossRef] [Google Scholar] [PubMed]
  12. Yin X, Giap C, Lazo JS, Prochownik EV (2003) Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene 22: 6151-6159 [CrossRef] [Google Scholar] [PubMed]
  13. Wang H, Hammoudeh DI, Follis AV, Reese BE, Lazo JS, et al. (2007) Improved low molecular weight Myc-Max inhibitors. Mol Cancer Ther 6: 2399-2408 [CrossRef] [Google Scholar] [PubMed]
  14. Follis AV, Hammoudeh DI, Wang H, Prochownik EV, Metallo SJ (2008) Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules. Chem Biol 15: 1149-1155 [CrossRef] [Google Scholar] [PubMed]
  15. Yap JL, Wang H, Hu A, Chauhan J, Jung KY, et al. (2013) Pharmacophore identification of c-Myc inhibitor 10074-G5. Bioorg Med Chem Lett 23: 370- 374 [CrossRef] [Google Scholar] [PubMed]
  16. Wang H, Chauhan J, Hu A, Pendleton K, Yap JL, et al. (2013) Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5. Oncotarget 4: 936-947 [CrossRef] [Google Scholar] [PubMed]
  17. Chauhan J, Wang H, Yap JL, Sabato PE, Hu A, et al. (2014) Discovery of methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]- 3-carboxylate, an improved small-molecule inhibitor of c-Myc-max dimerization. Chem Med Chem 9: 2274-2285 [CrossRef] [Google Scholar] [PubMed]
  18. Jung KY, Wang H, Teriete P, Yap JL, Chen L, et al.(2015) Perturbation of the c-Myc-Max protein-protein interaction via synthetic alpha-helix mimetics. J Med Chem 58: 3002-3024 [CrossRef] [Google Scholar] [PubMed]
  19. Berg T, Cohen SB, Desharnais J, Sonderegger C, Maslyar DJ, et al. (2002) Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc Natl Acad Sci U S A 99: 3830-3835 [CrossRef] [Google Scholar] [PubMed]
  20. Lu X, Vogt PK, Boger DL, Lunec J (2008) Disruption of the MYC transcriptional function by a small-molecule antagonist of MYC/MAX dimerization. Oncol Rep 19: 825-830 [CrossRef] [Google Scholar] [PubMed]
  21. Xu Y, Shi J, Yamamoto N, Moss JA, Vogt PK, et al. (2006) A credit-card library approach for disrupting protein-protein interactions. Bioorg Med Chem 14: 2660-2673 [CrossRef] [Google Scholar] [PubMed]
  22. Hart JR, Garner AL, Yu J, Ito Y, Sun M, et al. (2014) Inhibitor of MYC identified in a Krohnke pyridine library. Proc Natl Acad Sci U S A 111: 12556-12561 [CrossRef] [Google Scholar] [PubMed]
  23. Kiessling A, Wiesinger R, Sperl B, Berg T (2007) Selective inhibition of c-Myc/Max dimerization by a pyrazolo[1,5-a]pyrimidine. Chem Med Chem 2: 627-630 [CrossRef] [Google Scholar] [PubMed]
  24. Mo H, Henriksson M (2006) Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation. Proc Natl Acad Sci U S A 103: 6344-6349 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.